Latest filing published 02 Feb 2011 for KING PHARMACEUTICALS INC.
No signal scores available.
This profile gathers the share dealings of Gregory D. Jordan in King Pharmaceuticals Inc. The record holds 7 filings, for trades running from 28 April 2006 to 31 January 2011.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 2 February 2011, reports a transaction in King Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations